UCB SA (UCB-BT)

QUOTE AND NEWS
The Hindu Business Line  Mar 27  Comment 
StemCyte India Therapeutics, a unit of StemCyte Inc., USA, will open more centres across India to collect umbilical cord blood (UCB) units and go for public banking of stem cells in a big way for...
FierceBiotech  Mar 11  Comment 
Sanofi is joining forces with UCB to study new small-molecule approaches to treating inflammatory conditions like arthritis, looking for an easier form of administration to some of the blockbuster injected biologics that dominate the field. The...
FiercePharma  Feb 20  Comment 
UCB is preparing for a changing of the guard. The Belgium-based drugmaker has tapped Jean-Christophe Tellier, who heads up its biopharma brands unit, to take over as CEO beginning next year, replacing current chief Roch Doliveux.
StreetInsider.com  Jan 2  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Amgen+%28AMGN%29%2C+UCB+Report+Publication+of+Signifcant+Results+from+Romosozumab+Phase+2/9015993.html for the full story.
Stock Blog Hub  Aug 20  Comment 
UCB (UCBJF) recently presented data from a study showing the effect of Neupro on cardiovascular measures in patients with restless legs syndrome (RLS). The double-blind, placebo-controlled study showed reduction in total nocturnal systolic...
FiercePharma  Jul 24  Comment 
The regulators have spoken on both sides of the Atlantic. And in both cases, we have winners--and we have losers.
The Hindu Business Line  Jul 22  Comment 
Multinational pharma company UCB has filed a patent infringement case on many Indian pharma companies including Hyderabad-based Aurobindo Pharma Ltd on anti-seizures drug Vimpat. A petitio...
Reuters  Jul 19  Comment 
Belgian drugmaker UCB has been visited by Chinese authorities as the country widens investigations into bribery by drugmakers, following allegations against Britain's GlaxoSmithKline.





You may also be interested in articles related to UCB SA (UCB-BT):
 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki